ADIAL PHARMACEUTICALS, INC.·4

Mar 12, 6:46 PM ET

Truluck Joseph 4

4 · ADIAL PHARMACEUTICALS, INC. · Filed Mar 12, 2019

Insider Transaction Report

Form 4
Period: 2019-03-10
Truluck Joseph
Chief Financial Officer
Transactions
  • Award

    Stock Option

    2019-03-10+180,000180,000 total
    Exercise: $3.39From: 2019-04-10Exp: 2029-03-09Common Stock (180,000 underlying)
Footnotes (1)
  • [F1]These options vest pro rata on a monthly basis over 36 months.

Documents

1 file
  • 4
    ownership.xmlPrimary